血压自我监测对高危妊娠期高血压诊断的影响:BUMP 1 随机临床试验
这项非盲随机临床试验纳入2441名子痫前期高危孕妇,比较血压自我监测联合远程监测与常规产前保健对高血压诊断时间的影响。结果显示两组从随机化到临床记录高血压的时间无显著差异(平均差值-1.6天,95%CI -8.1至4.9,P=0.64)。
要点
- 高危妊娠中血压自我监测联合远程监测未显著提前临床高血压诊断时间。
- 自我监测组与常规保健组的高血压记录时间平均差值-1.6天(95%CI -8.1至4.9,P=0.64)。
- 18例严重不良事件中无判定与干预相关(自我监测组12例[1%] vs 常规组6例[0.5%])。
核心结论
- 在子痫前期高危孕妇中,与常规保健相比,血压自我监测联合远程监测未显著提前基于临床的高血压诊断时间。
研究设计与样本
- 非盲随机临床试验,纳入2441名子痫前期高危孕妇,平均孕20周,从英格兰15个医院产科单位招募,招募时间为2018年11月至2019年10月,最终随访于2020年4月完成。
- 参与者随机分为血压自我监测联合远程监测加常规保健组(n=1223)或单独常规产前保健组(n=1218,无法获取远程监测血压)。
- 主要结局为卫生保健专业人员首次记录高血压的时间。
主要发现
- 2441名随机参与者平均年龄33岁(SD 5.6),平均孕周20周(SD 1.6),2346名(96%)完成试验。
- 从随机化到临床记录高血压的时间在自我监测组(平均104.3天,SD 32.6)与常规保健组(平均106.2天,SD 32.0)之间无显著差异(平均差值-1.6天,95%CI -8.1至4.9,P=0.64)。
- 试验期间报告18例严重不良事件,无判定与干预相关(自我监测组12例[1%] vs 常规保健组6例[0.5%])。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Inadequate management of elevated blood pressure (BP) is a significant contributing factor to maternal deaths. Self-monitoring of BP in the general population has been shown to improve the diagnosis and management of hypertension; however, little is known about its use in pregnancy. OBJECTIVE: To determine whether self-monitoring of BP in higher-risk pregnancies leads to earlier detection of pregnancy hypertension. DESIGN, SETTING, AND PARTICIPANTS: Unblinded, randomized clinical trial that included 2441 pregnant individuals at higher risk of preeclampsia and recruited at a mean of 20 weeks' gestation from 15 hospital maternity units in England between November 2018 and October 2019. Final follow-up was completed in April 2020. INTERVENTIONS: Participating individuals were randomized to either BP self-monitoring with telemonitoring (n = 1223) plus usual care or usual antenatal care alone (n = 1218) without access to telemonitored BP. MAIN OUTCOMES AND MEASURES: The primary outcome was time to first recorded hypertension measured by a health care professional. RESULTS: Among 2441 participants who were randomized (mean [SD] age, 33 [5.6] years; mean gestation, 20 [1.6] weeks), 2346 (96%) completed the trial. The time from randomization to clinic recording of hypertension was not significantly different between individuals in the self-monitoring group (mean [SD], 104.3 [32.6] days) vs in the usual care group (mean [SD], 106.2 [32.0] days) (mean difference, -1.6 days [95% CI, -8.1 to 4.9]; P = .64). Eighteen serious adverse events were reported during the trial with none judged as related to the intervention (12 [1%] in the self-monitoring group vs 6 [0.5%] in the usual care group). CONCLUSIONS AND RELEVANCE: Among pregnant individuals at higher risk of preeclampsia, blood pressure self-monitoring with telemonitoring, compared with usual care, did not lead to significantly earlier clinic-based detection of hypertension. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03334149.
引用
- Tucker KL, Mort S, Yu LM, et al. Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial. JAMA. 2022. PMID: 35503346. doi:10.1001/jama.2022.4712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。